Results 11 to 20 of about 12,090 (148)

Therapeutic Targeting of Exportin-1 in Childhood Cancer [PDF]

open access: yesCancers, 2021
Overexpression of Exportin-1 (XPO1), a key regulator of nuclear-to-cytoplasmic transport, is associated with inferior patient outcomes across a range of adult malignancies. Targeting XPO1 with selinexor has demonstrated promising results in clinical trials, leading to FDA approval of its use for multiple relapsed/refractory cancers.
Daniel A Weiser   +2 more
exaly   +5 more sources

Human Exportin-1 is a Target for Combined Therapy of HIV and AIDS Related Lymphoma [PDF]

open access: yesEBioMedicine, 2015
Infection with HIV ultimately leads to advanced immunodeficiency resulting in an increased incidence of cancer. For example primary effusion lymphoma (PEL) is an aggressive non-Hodgkin lymphoma with very poor prognosis that typically affects HIV infected
Eline Boons   +13 more
doaj   +4 more sources

Nuclear egress of TDP-43 and FUS occurs independently of Exportin-1/CRM1 [PDF]

open access: yesScientific Reports, 2018
TDP-43 and FUS are nuclear proteins with multiple functions in mRNA processing. They play key roles in ALS (amyotrophic lateral sclerosis) and FTD (frontotemporal dementia), where they are partially lost from the nucleus and aggregate in the cytoplasm of
Helena Ederle   +7 more
doaj   +7 more sources

Nuclear exportin receptor CAS regulates the NPI-1-mediated nuclear import of HIV-1 Vpr. [PDF]

open access: yesPLoS ONE, 2011
Vpr, an accessory protein of human immunodeficiency virus type 1, is a multifunctional protein that plays an important role in viral replication. We have previously shown that the region between residues 17 and 74 of Vpr (Vpr(N17C74)) contained a bona ...
Eri Takeda   +6 more
doaj   +4 more sources

In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individuals. [PDF]

open access: yesPLoS ONE, 2018
Infection of immunocompromised individuals with normally benign opportunistic viruses is a major health burden globally. Infections with viruses such as Epstein-Barr virus (EBV), human cytomegalovirus (HCMV), Kaposi's sarcoma virus (KSHV), adenoviruses ...
Douglas G Widman   +3 more
doaj   +2 more sources

Exportin 1 inhibition as antiviral therapy. [PDF]

open access: yesDrug Discov Today, 2020
Coronavirus 2019 (COVID-19; caused by Severe Acute Respiratory Syndrome Coronavirus 2; SARS-CoV-2) is a currently global health problem. Previous studies showed that blocking nucleocytoplasmic transport with exportin 1 (XPO1) inhibitors originally developed as anticancer drugs can quarantine key viral accessory proteins and genomic materials in the ...
Uddin MH, Zonder JA, Azmi AS.
europepmc   +3 more sources

Targeting of nucleo‑cytoplasmic transport factor exportin 1 in malignancy (Review). [PDF]

open access: yesMed Int (Lond), 2022
Nuclear pore complexes (NPCs) regulate the entry and exit of molecules from the cell nucleus. Small molecules pass through NPCs by diffusion while large molecules enter and exit the nucleus by karyopherins, which serve as transport factors. Exportin-1 (XPO1) is a protein that is an important member of the karyopherin family and carries macromolecules ...
Özdaş S, Canatar İ.
europepmc   +4 more sources

Therapeutic targeting of exportin-1 beyond nuclear export. [PDF]

open access: yesTrends Pharmacol Sci
Exportin-1 (XPO1), also known as chromosome region maintenance 1 (CRM1), directly binds to and mediates the nuclear export of hundreds of cargo proteins. Blocking nuclear export by the selective inhibitors of nuclear export (SINEs) is a validated therapeutic axis in cancer and an active area of research.
Chen YF, Adams DJ.
europepmc   +3 more sources

XPO1E571K Mutation Modifies Exportin 1 Localisation and Interactome in B-cell Lymphoma. [PDF]

open access: yesCancers (Basel), 2020
The XPO1 gene encodes exportin 1 (XPO1) that controls the nuclear export of cargo proteins and RNAs. Almost 25% of primary mediastinal B-cell lymphoma (PMBL) and classical Hodgkin lymphoma (cHL) cases harboured a recurrent XPO1 point mutation (NM_003400, chr2:g61718472C>T) resulting in the E571K substitution within the hydrophobic groove of the ...
Miloudi H   +9 more
europepmc   +5 more sources

Home - About - Disclaimer - Privacy